Heartflow (AFFECTS)

计划入组 270 人 · 首次发布于 2016 年 11 月 25 日

HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT Angiography

计划入组 276 人 · 首次发布于 2012 年 12 月 31 日

ELUCIDATE FFRct Study

计划入组 439 人 · 首次发布于 2023 年 8 月 30 日

Antibody drug conjugate(MabPlex-Agilent ADC Analysis Joint Lab)

Lopinavir(Kaletra, Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan))

C₃₇H₄₈N₄O₅ · Rx

Tamoxifen(Soltamox)

C₂₆H₂₉NO · Rx

HEARTFLOW, INC.

United States

BOTEC ANALYSIS, LLC

United States

RESEARCH CENTER FOR IMMUNOLOGICAL ANALYSIS,INC

Japan

Heartflow FFRCT Analysis Cuts Unnecessary Invasive Heart Procedures by 44% in Government-Funded FUSION Trial

HeartFlow's AI-Powered FFRCT Analysis Demonstrates Long-Term Benefits in CAD Evaluation

HeartFlow Raises $364M in Oversubscribed IPO, Stock Surges 58% on Strong Investor Confidence